Search

Melasma treatment – what have we achieved in 42 years?

Melasma is a hyperpigmentation disorder which has been the subject of intense research over the last 40 years. As yet no definitive therapeutic strategy has been demonstrated to eradicate it or to avoid relapse. The author provides an up to...

Practising surgery in a war zone: an interview with Dr Volodymyr Melnyk

It is now nine months since the full-scale Russian invasion of Ukraine commenced in late February 2022, with Putin announcing a “special military operation” to “denazify and demilitarise” Ukraine. The rest of the world, however, saw it for what it...

Threads in rhinoplasty: to thread or not to thread?

Polydioxanone (PDO) and poly-L-lactic / poly-caprolactone (PLL / PCL) threads are presently accessible for facial rejuvenation, and they enjoy significant popularity within aesthetic clinics worldwide, especially in Southeast Asia [1–3]. Often proposed as risk-free with minimal downtime, these threads now...

Focus on: Cosmeceuticals (part 2)

To start the second part (see also Definitions, regulations and a review of the market and Skin anatomy and photoageing and Focus on: Cosmeceuticals (part 2) - continued) of this special focus on cosmeceuticals the authors will present some of...

Vascular complications part 2: management

- VIDEO CONTENT AT BOTTOM OF ARTICLE - Vascular complications from the use of soft tissue fillers can be devastating. In the second of a two-part series (click here for Part 1), the authors discuss how to manage these adverse...

In conversation with Miriam Martinez Callejas: an insight into compounding

In this conversation Miriam Martinez Callejas, a pharmacist and founder of Roseway Labs, chats to PMFA Editor, Andrew Burd, about the intricacies of compounding pharmaceuticals and how it can support both practitioners and patients. Miriam Martinez Callejas, Superintendent Pharmacist and...